Bring Order, Stability, and Control to your TMF Phlexglobal is unique among eTMF providers. We leverage dedicated and authoritative TMF technologies and expert services to bring order, stability, and control to your Trial Master File – helping you achieve the highest standards for completeness, timeliness, and quality.
CrO Biosciences, Inc., (CrO) is an information management consulting firm located in Temecula, CA. We provide regulatory submissions, GCP inspection readiness, clinical trial support, and R&D Systems Exchange services to pharmaceutical, biotechnology, and medical device organizations. CrO is a global, woman-owned, operated and controlled company, which consists of regulatory and clinical operations professionals with over 60 years of combined experience. Our unique methodologies are up to date with the current rules, regulations, guidances, technologies, and latest industry trends keeping us ahead of the curve every time.
Just in Time GCP provides clinical compliance consulting and clinical systems management services to support pharma and biotech companies in achieving operational excellence and inspection readiness through all phases of drug development. We have developed an infrastructure that has the capacity to support your organization in managing the oversight and day to day management of your Trial Master Files. Whether you are anticipating a regulatory inspection, need resourcing for routine quality oversight of your TMFs, or are planning the implementation of any clinical system, Just in Time GCP can support you. We have extensive industry experience in clinical operations and truly understand the complexities of trial management and drug development. We partner with your organization in ensuring that your TMFs and other clinical systems are inspection ready. We take the stress out of inspection readiness and TMF management.
We challenge the status quo in everything we do. Unified in our passion to bring therapies and an improved quality of life to patients around the world, inSeption Group is changing the outsourcing paradigm. Our foundational model disrupts the current, inefficient outsourcing model with higher-quality deliverables and far more consistent reliability. Driven by a vital mission to transform patient lives, inSeption Group's experts are defined by our incurable passion to offer hope and make a difference for the patients we are serving during their fight for a better, longer life. Our path-breaking model attracts those who demand a partner that share in their drive to conduct impeccable development and provide dependable solutions. inSeption provides transparency and faster access to data ensuring our decision-makers are armed with timely information and the clinical insights they need, creating a level of program control and visibility no one else can offer!
Through its portfolio of complementary brands, IBN provides (1) access to our network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release solutions so to ensure maximum impact, (4) full-scale distribution to a huge social media audience, (5) a full array of corporate communications focused on the IBN Podcast Series.
BioMedWire (BMW) is a specialized communications platform, a digital hub that aggregates and distributes news and information on the latest developments in the life sciences sector. Designed to quickly update investors on important industry news, BioMedWire is committed to keeping the public abreast of the latest developments related to emerging market opportunities in the sector.
PM360 is the premier, must-read magazine for marketing decision makers in the pharmaceutical, biotech, and medical device industries. Published monthly, PM360 is the only journal that focuses on delivering the full spectrum of practical information necessary for product managers and pharma marketing professionals to succeed in the complex and highly regulated healthcare environment.
PharmaVOICE magazine reaches more than 46,000 BPA qualified subscribers and 60,000 users with its digital edition. PharmaVOICE is the forum that allows business leaders to engage in a candid dialogue on the challenges and trends impacting the industry. PharmaVOICE provides readers with insightful and thought-provoking commentary in a multiple-perspective format through forums, topics, and articles covering a range of issues from molecule through market. PharmaVOICE subscribers are also kept abreast of the latest trends and information through additional media resources, including Social Media, WebLinx Interactive WebSeminars, Podcasts, Videocasts, White Papers, E-Surveys and e-Alerts.